Rare cancer share of oncology trial starts

RecordSTO-CKTWGAVX6E-RJR46BZNNY-VM2FPH

74%

Global · 2024

Rare cancer share of oncology trial starts worldwide was 74% in 2024 (IQVIA).

Original source

Rare cancer share of oncology trial starts: every country and year, and how it is measured

Publisher
IQVIA
Authority tier
T3 Research
Locator
Other Findings
Retrieved
16 Sep 2026
Status
Verified

What the source says

Most oncology trials are focused on rare cancers, with 74% of trial starts in 2024 evaluating medicines for rare cancers, growing by 3% compared to 2023.

Checked: the figure 74%is stated in this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

APA

IQVIA Institute. (2024). Global Oncology Trends 2025. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Via StatOrigin, https://statorigin.org/stat/stat_CKTWGAVX6ERJR46BZNNYVM2FPH

Other formats: MLA, Chicago, BibTeX
MLA
IQVIA Institute. "Global Oncology Trends 2025." 2024, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed 16 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_CKTWGAVX6ERJR46BZNNYVM2FPH.
Chicago
IQVIA Institute. "Global Oncology Trends 2025." 2024. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_CKTWGAVX6ERJR46BZNNYVM2FPH.
BibTeX
@misc{iqvia2024rarevm2fph, author = {{IQVIA Institute}}, title = {Global Oncology Trends 2025}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_CKTWGAVX6ERJR46BZNNYVM2FPH}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026.} }

Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of custody
Record: STO-CKTWGAVX6E-RJR46BZNNY-VM2FPH T3 Research

Primary source

Publisher
IQVIA Institute · homepage ↗
Authority tier
Tier 3 · Research and companies
Report
Global Oncology Trends 2025
Type
Press release
Published
—
Locator
Other Findings
Retrieved
16 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification

Status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Permanent URL
/stat/stat_CKTWGAVX6ERJR46BZNNYVM2FPH